Publications by authors named "S Sherratt"

Background: Endothelial cell (EC) dysfunction involves reduced nitric oxide (NO) bioavailability due to NO synthase uncoupling linked to increased oxidation and reduced cofactor availability. Loss of endothelial function and NO bioavailability are associated with inflammation, including leukocyte activation. Eicosapentaenoic acid (EPA) administered as icosapent ethyl reduced cardiovascular events in REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) in relation to on-treatment EPA blood levels.

View Article and Find Full Text PDF

Treatment for people with aphasia mainly concentrates on facilitating the communication of needs or providing facts. This focus is in danger of downplaying the significance of the expression of attitudes and emotion. Evaluative expression is critical for recreating identity and social interaction.

View Article and Find Full Text PDF
Article Synopsis
  • * While prescription-grade EPA-only formulations have demonstrated significant reductions in cardiovascular events for high-risk patients, mixtures of EPA and docosahexaenoic acid (DHA) have largely failed in effective prevention.
  • * The distinct clinical benefits of EPA over DHA and other O3FAs may stem from their unique biological properties, which influence various cardiovascular mechanisms beyond just lowering lipids.
View Article and Find Full Text PDF

Purpose: Climate change is considered to be the greatest threat to human health in the 21st century, and its effects are accelerating. Extensive research has clearly demonstrated its increasing impact across the continuum of health conditions. Despite this, there has been limited attention to the ramifications of climate change on hearing loss and hearing disorders.

View Article and Find Full Text PDF